Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 49 of 1,261
  1. US 12274723

    Bacteriophage compositions and methods for treatment of bacterial infections

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  2. US 12274735

    IL-4-fusion formulations for treatment of central nervous system (CNS) tumors

    Medicenna Therapeutics Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  3. US 12275769

    Activatable interleukin 12 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  4. US 12275957

    Next generation designer liver organoids and their methods of preparation and use

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  5. US 12275955

    Combining iPSC derived effector cell types for immunotherapy use

    Fate Therapeutics, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  6. US 12275940

    Conjugated antisense compounds and their use

    Ionis Pharmaceuticals, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  7. US 12274725

    Zika virus strains for treatment of glioma

    The Board of Regents of the University of Texas System · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  8. US 12275788

    Single-domain antibodies against CD33 and constructs thereof

    Legend Biotech Ireland Limited · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  9. US 12274747

    Compositions and methods for treating cytokine release syndrome

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  10. US 12274741

    Cattle fever tick-infestation vaccines and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  11. US 12275964

    Variant type V CRISPR/Cas effector polypeptides and methods of use thereof

    The Regents of the University of California · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  12. US 12275786

    Anti-thyroglobulin t cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  13. US 12275792

    Antigen-binding proteins that activate the leptin receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  14. US 12274684

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  15. US 12275966

    Genetically engineered cells

    The Regents of the University of California · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  16. US 12275685

    Oligo-benzamide analogs and their use in cancer treatment

    The Board of Regents of the University of Texas System · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  17. US 12268694

    Combination pharmaceutical agents as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  18. US 12268753

    Nanomaterials comprising a biodegradable feature

    Beam Therapeutics Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  19. US 12269808

    Amino dithioperacid thioester compound, preparation method therefor, and use thereof

    EAST CHINA NORMAL UNIVERSITY · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  20. US 12269155

    Multivalent vaccines for rabies virus and coronaviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  21. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  22. US 12269856

    Hepcidin analogues and uses thereof

    Protagonist Therapeutics, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  23. US 12268673

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  24. US 12269801

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.